Aquestive Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: AQST · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1398733
| Field | Detail |
|---|---|
| Company | Aquestive Therapeutics, Inc. (AQST) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, shareholder-vote, 8-k
Related Tickers: AQST
TL;DR
AQST filed an 8-K for a shareholder vote - governance update.
AI Summary
Aquestive Therapeutics, Inc. filed an 8-K on June 11, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate actions and governance decisions as of that date. No specific financial transactions or significant business events were detailed in this particular filing.
Why It Matters
This filing indicates that Aquestive Therapeutics held or is reporting on a shareholder vote, which is a key governance event that can impact corporate direction and shareholder rights.
Risk Assessment
Risk Level: low — This filing is procedural and relates to corporate governance, not a significant event like a merger, acquisition, or financial distress.
Key Players & Entities
- Aquestive Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 30 Technology Drive Warren, NJ 07059 (address) — Principal Executive Offices
- MonoSol Rx, Inc. (company) — Former Company Name
FAQ
What specific matters were submitted to a vote of Aquestive Therapeutics' security holders?
The filing states that it is a report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on 'Submission of Matters to a Vote of Security Holders'. However, the specific details of the matters voted upon are not enumerated within the provided text excerpt.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 11, 2025.
What is the principal executive office address for Aquestive Therapeutics, Inc.?
The principal executive offices are located at 30 Technology Drive, Warren, NJ 07059.
What was Aquestive Therapeutics, Inc.'s former name?
The company's former name was MonoSol Rx, Inc., with a date of name change on May 7, 2007.
Under which state is Aquestive Therapeutics, Inc. incorporated?
Aquestive Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Aquestive Therapeutics, Inc. (AQST).